Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

488 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, Lee SJ, van den Broek JJ, Huang X, Schechter CB, Sprague BL, Song J, de Koning HJ, Trentham-Dietz A, van Ravesteyn NT, Gangnon R, Chandler Y, Li Y, Xu C, Ergun MA, Huang H, Berry DA, Mandelblatt JS. Plevritis SK, et al. Among authors: de koning hj. JAMA. 2018 Jan 9;319(2):154-164. doi: 10.1001/jama.2017.19130. JAMA. 2018. PMID: 29318276 Free PMC article.
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG; Magnetic Resonance Imaging Screening Study Group. Kriege M, et al. Among authors: de koning hj. N Engl J Med. 2004 Jul 29;351(5):427-37. doi: 10.1056/NEJMoa031759. N Engl J Med. 2004. PMID: 15282350 Free article.
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M, Brekelmans CT, Boetes C, Muller SH, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Rutgers EJ, de Koning HJ, Klijn JG; Dutch MRI Screening (MRISC) Study Group. Kriege M, et al. Among authors: de koning hj. Cancer. 2006 Jun 1;106(11):2318-26. doi: 10.1002/cncr.21863. Cancer. 2006. PMID: 16615112 Free article.
Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.
Kriege M, Brekelmans CT, Obdeijn IM, Boetes C, Zonderland HM, Muller SH, Kok T, Manoliu RA, Besnard AP, Tilanus-Linthorst MM, Seynaeve C, Bartels CC, Kaas R, Meijer S, Oosterwijk JC, Hoogerbrugge N, Tollenaar RA, Rutgers EJ, de Koning HJ, Klijn JG. Kriege M, et al. Among authors: de koning hj. Breast Cancer Res Treat. 2006 Nov;100(1):109-19. doi: 10.1007/s10549-006-9230-z. Epub 2006 Jun 22. Breast Cancer Res Treat. 2006. PMID: 16791481
The MISCAN-Fadia continuous tumor growth model for breast cancer.
Tan SY, van Oortmarssen GJ, de Koning HJ, Boer R, Habbema JD. Tan SY, et al. Among authors: de koning hj. J Natl Cancer Inst Monogr. 2006;(36):56-65. doi: 10.1093/jncimonographs/lgj009. J Natl Cancer Inst Monogr. 2006. PMID: 17032895
Breast cancer screening: evidence for false reassurance?
de Gelder R, van As E, Tilanus-Linthorst MM, Bartels CC, Boer R, Draisma G, de Koning HJ. de Gelder R, et al. Among authors: de koning hj. Int J Cancer. 2008 Aug 1;123(3):680-6. doi: 10.1002/ijc.23540. Int J Cancer. 2008. PMID: 18484587 Free article.
488 results